Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis

Preclinical studies have shown benefit of apolipoprotein A-I (apoA-I)/high-density lipoprotein (HDL) raising in atherosclerosis; however, this has not yet translated into a successful clinical therapy. Our studies demonstrate that apoA-I raising is more effective at reducing early-stage atherosclero...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JACC Basic Transl Sci
Main Authors: Morton, Jamie, Bao, Shisan, Vanags, Laura Z., Tsatralis, Tania, Ridiandries, Anisyah, Siu, Chung-Wah, Ng, Kwong-Man, Tan, Joanne T.M., Celermajer, David S., Ng, Martin K.C., Bursill, Christina A.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
PRECLINICAL RESEARCH
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059906/
https://ncbi.nlm.nih.gov/pubmed/30062204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2017.11.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados